Logo image of EBIX

EBIX INC (EBIX) Stock Fundamental Analysis

USA - NASDAQ:EBIX - US2787152063 - Common Stock

1.16 USD
-0.55 (-32.16%)
Last: 12/27/2023, 8:25:48 PM
1.1603 USD
+0 (+0.03%)
After Hours: 12/27/2023, 8:25:48 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to EBIX. EBIX was compared to 282 industry peers in the Software industry. There are concerns on the financial health of EBIX while its profitability can be described as average. EBIX is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

EBIX had positive earnings in the past year.
EBIX had a positive operating cash flow in the past year.
In the past 5 years EBIX has always been profitable.
Each year in the past 5 years EBIX had a positive operating cash flow.
EBIX Yearly Net Income VS EBIT VS OCF VS FCFEBIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.32%, EBIX is in the better half of the industry, outperforming 71.94% of the companies in the same industry.
EBIX's Return On Equity of 0.82% is fine compared to the rest of the industry. EBIX outperforms 73.74% of its industry peers.
EBIX has a better Return On Invested Capital (13.72%) than 94.24% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EBIX is in line with the industry average of 11.88%.
The last Return On Invested Capital (13.72%) for EBIX is above the 3 year average (10.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.32%
ROE 0.82%
ROIC 13.72%
ROA(3y)4.81%
ROA(5y)5.26%
ROE(3y)11.98%
ROE(5y)14.6%
ROIC(3y)10.38%
ROIC(5y)10.3%
EBIX Yearly ROA, ROE, ROICEBIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 5 10 15 20

1.3 Margins

The Profit Margin of EBIX (0.68%) is better than 72.30% of its industry peers.
EBIX's Profit Margin has declined in the last couple of years.
EBIX has a better Operating Margin (14.94%) than 86.69% of its industry peers.
EBIX's Operating Margin has declined in the last couple of years.
EBIX's Gross Margin of 47.00% is on the low side compared to the rest of the industry. EBIX is outperformed by 69.06% of its industry peers.
In the last couple of years the Gross Margin of EBIX has declined.
Industry RankSector Rank
OM 14.94%
PM (TTM) 0.68%
GM 47%
OM growth 3Y-24.69%
OM growth 5Y-18.1%
PM growth 3Y-28.25%
PM growth 5Y-25.95%
GM growth 3Y-21.49%
GM growth 5Y-13.45%
EBIX Yearly Profit, Operating, Gross MarginsEBIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EBIX is creating value.
Compared to 1 year ago, EBIX has more shares outstanding
The debt/assets ratio for EBIX is higher compared to a year ago.
EBIX Yearly Shares OutstandingEBIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
EBIX Yearly Total Debt VS Total AssetsEBIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

Based on the Altman-Z score of 1.06, we must say that EBIX is in the distress zone and has some risk of bankruptcy.
EBIX has a Altman-Z score of 1.06. This is in the lower half of the industry: EBIX underperforms 61.87% of its industry peers.
EBIX has a debt to FCF ratio of 30.67. This is a negative value and a sign of low solvency as EBIX would need 30.67 years to pay back of all of its debts.
The Debt to FCF ratio of EBIX (30.67) is comparable to the rest of the industry.
EBIX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.03, EBIX is doing good in the industry, outperforming 61.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 30.67
Altman-Z 1.06
ROIC/WACC2.69
WACC5.1%
EBIX Yearly LT Debt VS Equity VS FCFEBIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.41 indicates that EBIX may have some problems paying its short term obligations.
EBIX has a worse Current ratio (0.41) than 95.32% of its industry peers.
A Quick Ratio of 0.41 indicates that EBIX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.41, EBIX is doing worse than 95.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.41
Quick Ratio 0.41
EBIX Yearly Current Assets VS Current LiabilitesEBIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for EBIX have decreased strongly by -92.74% in the last year.
Measured over the past years, EBIX shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.91% on average per year.
EBIX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.72%.
Measured over the past years, EBIX shows a very strong growth in Revenue. The Revenue has been growing by 23.60% on average per year.
EPS 1Y (TTM)-92.74%
EPS 3Y-14.5%
EPS 5Y-7.91%
EPS Q2Q%-155.93%
Revenue 1Y (TTM)-30.72%
Revenue growth 3Y21.84%
Revenue growth 5Y23.6%
Sales Q2Q%-53.78%

3.2 Future

The Earnings Per Share is expected to decrease by -17.98% on average over the next years. This is quite bad
The Revenue is expected to decrease by -31.80% on average over the next years. This is quite bad
EPS Next Y-87.37%
EPS Next 2Y-17.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-42.79%
Revenue Next 2Y-31.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EBIX Yearly Revenue VS EstimatesEBIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
EBIX Yearly EPS VS EstimatesEBIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3

More info and screens

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 6.82, the valuation of EBIX can be described as very cheap.
Based on the Price/Earnings ratio, EBIX is valued cheaper than 96.76% of the companies in the same industry.
EBIX is valuated cheaply when we compare the Price/Earnings ratio to 27.49, which is the current average of the S&P500 Index.
EBIX is valuated cheaply with a Price/Forward Earnings ratio of 0.82.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EBIX indicates a rather cheap valuation: EBIX is cheaper than 100.00% of the companies listed in the same industry.
EBIX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 6.82
Fwd PE 0.82
EBIX Price Earnings VS Forward Price EarningsEBIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EBIX is valued cheaper than 97.84% of the companies in the same industry.
99.64% of the companies in the same industry are more expensive than EBIX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.74
EV/EBITDA 4.14
EBIX Per share dataEBIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The decent profitability rating of EBIX may justify a higher PE ratio.
A cheap valuation may be justified as EBIX's earnings are expected to decrease with -17.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.98%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EBIX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EBIX INC

NASDAQ:EBIX (12/27/2023, 8:25:48 PM)

After market: 1.1603 +0 (+0.03%)

1.16

-0.55 (-32.16%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-13 2024-03-13/amc
Inst Owners0.52%
Inst Owner Change0%
Ins Owners25.36%
Ins Owner Change0%
Market Cap35.84M
Analysts85.71
Price Target15.05 (1197.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)0.25%
DP46%
Div Incr Years0
Div Non Decr Years9
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-313.68%
Min EPS beat(2)-531.37%
Max EPS beat(2)-96%
EPS beat(4)0
Avg EPS beat(4)-178.32%
Min EPS beat(4)-531.37%
Max EPS beat(4)-32.69%
EPS beat(8)2
Avg EPS beat(8)-91.14%
EPS beat(12)3
Avg EPS beat(12)-65.24%
EPS beat(16)4
Avg EPS beat(16)-45.59%
Revenue beat(2)0
Avg Revenue beat(2)-15.05%
Min Revenue beat(2)-24.13%
Max Revenue beat(2)-5.97%
Revenue beat(4)0
Avg Revenue beat(4)-8.43%
Min Revenue beat(4)-24.13%
Max Revenue beat(4)-0.34%
Revenue beat(8)3
Avg Revenue beat(8)5.53%
Revenue beat(12)6
Avg Revenue beat(12)7.6%
Revenue beat(16)7
Avg Revenue beat(16)6.13%
PT rev (1m)0%
PT rev (3m)-33.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.76%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.67%
Valuation
Industry RankSector Rank
PE 6.82
Fwd PE 0.82
P/S 0.05
P/FCF 1.74
P/OCF 1
P/B 0.06
P/tB N/A
EV/EBITDA 4.14
EPS(TTM)0.17
EY14.66%
EPS(NY)1.41
Fwd EY121.78%
FCF(TTM)0.67
FCFY57.47%
OCF(TTM)1.16
OCFY100.16%
SpS23.81
BVpS19.78
TBVpS-11.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.32%
ROE 0.82%
ROCE 15.78%
ROIC 13.72%
ROICexc 15.67%
ROICexgc N/A
OM 14.94%
PM (TTM) 0.68%
GM 47%
FCFM 2.8%
ROA(3y)4.81%
ROA(5y)5.26%
ROE(3y)11.98%
ROE(5y)14.6%
ROIC(3y)10.38%
ROIC(5y)10.3%
ROICexc(3y)12%
ROICexc(5y)11.71%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.77%
ROCE(5y)11.72%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y20.04%
ROICexc growth 5Y10.36%
OM growth 3Y-24.69%
OM growth 5Y-18.1%
PM growth 3Y-28.25%
PM growth 5Y-25.95%
GM growth 3Y-21.49%
GM growth 5Y-13.45%
F-Score5
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 30.67
Debt/EBITDA 0.12
Cap/Depr 70.18%
Cap/Sales 2.08%
Interest Coverage 1.86
Cash Conversion 27.26%
Profit Quality 412%
Current Ratio 0.41
Quick Ratio 0.41
Altman-Z 1.06
F-Score5
WACC5.1%
ROIC/WACC2.69
Cap/Depr(3y)75.83%
Cap/Depr(5y)84.35%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.07%
Profit Quality(3y)89.22%
Profit Quality(5y)78.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-92.74%
EPS 3Y-14.5%
EPS 5Y-7.91%
EPS Q2Q%-155.93%
EPS Next Y-87.37%
EPS Next 2Y-17.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.72%
Revenue growth 3Y21.84%
Revenue growth 5Y23.6%
Sales Q2Q%-53.78%
Revenue Next Year-42.79%
Revenue Next 2Y-31.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.65%
EBIT growth 3Y-8.24%
EBIT growth 5Y1.22%
EBIT Next Year21.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-62.55%
FCF growth 3Y5.41%
FCF growth 5Y-3.37%
OCF growth 1Y-47.51%
OCF growth 3Y8.47%
OCF growth 5Y0.21%